Morgan Stanley Haleon PLC Transaction History
Morgan Stanley
- $1.59 Trillion
- Q3 2025
A detailed history of Morgan Stanley transactions in Haleon PLC stock. As of the latest transaction made, Morgan Stanley holds 18,532,527 shares of HLN stock, worth $178 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
18,532,527
Previous 17,734,937
4.5%
Holding current value
$178 Million
Previous $184 Million
9.61%
% of portfolio
0.01%
Previous 0.01%
Shares
19 transactions
Others Institutions Holding HLN
# of Institutions
684Shares Held
451MCall Options Held
114KPut Options Held
25.7K-
Dodge & Cox San Francisco, CA154MShares$1.48 Billion0.8% of portfolio
-
Clearbridge Investments, LLC New York, NY33.3MShares$320 Million0.24% of portfolio
-
Harding Loevner LP Bridgewater, NJ17.9MShares$172 Million1.22% of portfolio
-
Wellington Management Group LLP Boston, MA15.7MShares$150 Million0.03% of portfolio
-
Jpmorgan Chase & CO New York, NY12MShares$115 Million0.01% of portfolio
About Haleon plc
- Ticker HLN
- Exchange
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 4,617,290,240
- Market Cap $44.3B
- Description
- Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, mineral...